Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Anthrax action shapes up

24.10.2001


Anthrax is under close scrutiny.
© AP/Fort Detrick, US Army


Washington’s Dirkin Senate Office gets a careful clean-up.
© AP/Kenneth Lambert


Researchers find two new leads for anti-anthrax drugs.

As fears over bioterrorism attacks spiral, researchers are making progress towards better anthrax drugs - but these are unlikely to reach the drugstore soon.

Of ten confirmed anthrax cases in the United States by Monday, four have been of the severe, inhaled form against which antibiotics often fail. By the time drugs destroy the bacteria responsible, Bacillus anthracis, the organisms have released enough lethal toxin to kill immune cells in the blood, causing fatal blood poisoning.



Two new discoveries lay the groundwork for drugs that could disable the toxin and, along with antibiotics, save lives.

John Young, of the University of Wisconsin in Madison, and his colleagues have pinpointed the protein, on the surface of human cells, which the anthrax toxin latches onto1. In the lab a synthetic version of this ’receptor’ mops up the poison and protects cells. "It serves as a decoy," Young explains.

Part of the toxin attaches to this receptor, punches a hole in the human cell membrane and injects another part, the ’lethal factor’, which destroys proteins in the cell. A second team, led by Robert Liddington of The Burnham Institute in La Jolla, California, have deduced the structure of this lethal factor2.

With a picture of how the toxin’s proteins attack cells, drug companies can search for chemicals that block their activity, the teams hope.

This promise is unlikely to be realized in time to help the current situation, Young and Liddington caution - most optimistic estimates are that improvements will be a year in the making. "We need to design drugs - not for this time round but for the next one," says Liddington.

Alternative medicine

The current crisis gives the hunt for effective treatments new urgency. What we have is no longer "state-of-the-art", says Richard Corlin, director of the American Medical Association in Chicago, Illinois. The latest work "will lead us to a better treatment", he agrees.

Excessive use of an existing antibiotic, ciprofloxacin, could create its own medical problems, Corlin warns. The drug destroys healthy bacteria in the body, so may leave people open to infection from other pathogens.

Overuse of antibiotics and failure to complete the 60-day course virtually "guarantee the emergence of antibiotic resistant strains" of these pathogenic bacteria, he says, making such infections difficult to treat.

Bioterrorists could potentially engineer antibiotic-resistant anthrax. Manufacturing bacteria able to withstand toxin-targeted drugs would be "almost impossible", says John Collier of Harvard Medical School, who contributed to both studies. It would require expert biochemical knowledge to alter specific protein shapes and interactions.

The anthrax vaccine is also problematic. Developed in the 1960s, it involves injecting a crude mix of the toxin’s protein components to stimulate resistance. Vaccination requires six shots and regular boosters. The vaccine is currently produced only in sufficient quantities for the US military.

Several groups are designing more effective versions using purified proteins, explains anthrax researcher Stephen Leppla of the National Institute of Dental and Craniofacial Reseach in Bethesda, Maryland. These are easily administered and produce long-lasting immunity. "Before too long, we’ll have it," he predicts.

Ultimately, we need a whole new arsenal to fight anthrax, says Collier - a new antibiotic, a safe, efficient vaccine, and drugs against toxins. Realizing this goal requires further funding for research and fast-track approval of candidate drugs, he suggests.

Meanwhile most people agree that heightened awareness remains the best form of defence, catching early, cold-like symptoms in time for the disease to be treated. "The key thing is an appropriate degree of surveillance," says Corbin.

Spore show

Anthrax spores, the persistent, dormant form of the bacterium, can cause infection through the skin and intestine, but inhalation is the most dangerous - around 90% of cases result in death.

Turning anthrax into an effective bioweapon is technically difficult - spores must be milled down into a very fine powder (less than 5 micrometres in diameter) for them to reach the depths of the lungs in sufficient quantities to cause infection. A dose of around 10,000 spores is thought to cause a lethal infection.

Spores sent in letters to media and political organizations in the United States had produced ten confirmed cases by the end of Monday, including one death. The deaths of two more postal workers have been linked to the disease. The source of the letters has not yet been found, and the United States is offering a $1-million reward for information leading to the identification of those responsible.

References
  1. Bradley, K.A., Mogridge, J., Mourez, M., Collier, R.J. & Young, J.A.T. Identification of the cellular receptor for the anthrax toxin. Nature, (2001).

  2. Panniter, A. et al. Crystal structure of the anthrax lethal factor. Nature, (2001).


HELEN PEARSON | Nature News Service
Further information:
http://www.nature.com/nsu/011025/011025-9.html
http://www.nature.com/nsu/

More articles from Health and Medicine:

nachricht NIST scientists discover how to switch liver cancer cell growth from 2-D to 3-D structures
17.11.2017 | National Institute of Standards and Technology (NIST)

nachricht High speed video recording precisely measures blood cell velocity
15.11.2017 | ITMO University

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: A “cosmic snake” reveals the structure of remote galaxies

The formation of stars in distant galaxies is still largely unexplored. For the first time, astron-omers at the University of Geneva have now been able to closely observe a star system six billion light-years away. In doing so, they are confirming earlier simulations made by the University of Zurich. One special effect is made possible by the multiple reflections of images that run through the cosmos like a snake.

Today, astronomers have a pretty accurate idea of how stars were formed in the recent cosmic past. But do these laws also apply to older galaxies? For around a...

Im Focus: Visual intelligence is not the same as IQ

Just because someone is smart and well-motivated doesn't mean he or she can learn the visual skills needed to excel at tasks like matching fingerprints, interpreting medical X-rays, keeping track of aircraft on radar displays or forensic face matching.

That is the implication of a new study which shows for the first time that there is a broad range of differences in people's visual ability and that these...

Im Focus: Novel Nano-CT device creates high-resolution 3D-X-rays of tiny velvet worm legs

Computer Tomography (CT) is a standard procedure in hospitals, but so far, the technology has not been suitable for imaging extremely small objects. In PNAS, a team from the Technical University of Munich (TUM) describes a Nano-CT device that creates three-dimensional x-ray images at resolutions up to 100 nanometers. The first test application: Together with colleagues from the University of Kassel and Helmholtz-Zentrum Geesthacht the researchers analyzed the locomotory system of a velvet worm.

During a CT analysis, the object under investigation is x-rayed and a detector measures the respective amount of radiation absorbed from various angles....

Im Focus: Researchers Develop Data Bus for Quantum Computer

The quantum world is fragile; error correction codes are needed to protect the information stored in a quantum object from the deteriorating effects of noise. Quantum physicists in Innsbruck have developed a protocol to pass quantum information between differently encoded building blocks of a future quantum computer, such as processors and memories. Scientists may use this protocol in the future to build a data bus for quantum computers. The researchers have published their work in the journal Nature Communications.

Future quantum computers will be able to solve problems where conventional computers fail today. We are still far away from any large-scale implementation,...

Im Focus: Wrinkles give heat a jolt in pillared graphene

Rice University researchers test 3-D carbon nanostructures' thermal transport abilities

Pillared graphene would transfer heat better if the theoretical material had a few asymmetric junctions that caused wrinkles, according to Rice University...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Ecology Across Borders: International conference brings together 1,500 ecologists

15.11.2017 | Event News

Road into laboratory: Users discuss biaxial fatigue-testing for car and truck wheel

15.11.2017 | Event News

#Berlin5GWeek: The right network for Industry 4.0

30.10.2017 | Event News

 
Latest News

Antarctic landscape insights keep ice loss forecasts on the radar

20.11.2017 | Earth Sciences

Filling the gap: High-latitude volcanic eruptions also have global impact

20.11.2017 | Earth Sciences

Water world

20.11.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>